AI assistant
Triochem Products Ltd. Interim / Quarterly Report 2021
63375_rns_2021-08-14_29704ed0-ccbc-45b0-89a9-024bfe46d7a4.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
MANUFACTURERS OF ETHICAI. PIIARRACEUTICAI. PRODUCTS Registered Office: 4th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbal, Mcharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fan 00 91 (22) 2202 4657 Email: [email protected] Wdbsite: www.triochemoroducts.com Corporate Identity Number: L24249MH 1972PLC015544
TRto b!iEM-,, EE
Ref No: TPL PP 2021625 2021; 14th August 2021
To BSE Limited Corporate Relationship Department, Phiroze jeejeebhoy Towers, Dalal Street, Fort.Muminbal400001. Security Code No. 512101. ISIN No.: INE331E01013.
Dear Sir / Madatry
Sub: Subnrission Of Unaudited Financial Results for the Ouarter ended 30th Tune 2021
We refer to our letter dated 6th August 2021 on the captioned subject.
Pursuant to Regulation 30 and 33 Of SEBI Qjsting Obligations and Disclosure Requirements) Regulations, 2015, In this subject, we wish to infom you that the Board Of Director Of the Company at its meeting held today i.e. Saturday, 14th August, 2021 have interLalia considered and approved the Unaudited Financial Results Of the Company for the quarter cndcd 30th June, 2021 duly reviewed by the Audit Committee.
The said financial results, duly signed by the Director & CEO Of the conipany along whh the statutory auditor's report are enclosed for your perusal and records.
Also, informed that the audited financial results in prescribed format will be published in "Free Press }ournal" and "Navshakti" newspaper, as required. Please take the same in your record.
Thandngyou,
your faithfully,
For TRIOCIIEM PRODUCTS LIMITED
`,.,.-
RAMU S. DEORA DIRECTOR & CEO DIN: 00312369 Encl.: as above
Kanu Doshi Associates LLP
Charteied Accountants
Pure Address : 123, Sohrab Hall, 21 Sassoon Road, Opp Jchangir Hospital. Pure -411001. T : 020 4906 7177 E : infa@kdg,co.in . W : ww\Ii.kdg.co.in
Independent Auditor's Review Report on Unaudited Quarterly Flnancial Results of the Company Pursuant to the Regulation 33 of the SEBl (L[st]ng Obligations and Disclosure Requ[rements) Regulations, 2015 (as amended)
To,
The Board of Dlrectors of TRIOCHEWI PRODUCTS LIMITED ("Company")
-
- We have reviewed the accompanying statement Of unaudited financial results of TRIOCHEM PRODUCTS LIMITED ("Company") for the quarter ended June 30, 2021 being submitted by the Company pursuant to Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including relevant circulars issued by SEBl from time tl time. The statement is the responsibility of the Company's management and has been approved by Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review of the Statement, which has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("lnd As 34"), specified under Section 133 Of the Companies Act, 2013, SEBI Circular CIR/CFD/PAC/62/2016 dated 5 July 2016 (hereinafter referred to as 'the SEBI Circular'), and other accounting principles generally accepted in India.
-
- We conducted our review of the statement in accordance with the Standard on Review Engagement (SRE) 2410, .Review Of Interim Financial Information performed by Independent Auditor of the Entfty' issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and an analytical procedure applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
-
- Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in acoordance with applicable Indian Accounting Standards (lnd AS) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement.
For Kanu Doshi Associates LLP Chartered Acoountants Firm Registration No: 104746WAV100096
KUNALSUMANT?Jg+#WSJgAn#AbRYAKUNAL VAKHARIA %Fi3,021 o8.1414:44D8
Kunal Vakharia Partner Membership No.: 148916 UDIN: 21148916AAAAFZ2977
Place: Mumbai Date: 14th August 2021
Registered Office: 4th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00.91 (22) 2266 3150 Fax: 00.91 (22) 2202 4657 E-mall: [email protected]
Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544
TRIOCHEM PRODUCTS LIMITED
Registered Office: Sambava Chambers, 4th Floor, Sir P. M. Road, Fort, Mumbai - 400 001
website: www.triochemproducts.com
CIN: L24249MH1972PLC015544
STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2021
| (Rs. in lakhs) Except EPS | ||||||
|---|---|---|---|---|---|---|
| $S_{\Gamma}$ | Particulars | Quarter Ended | Year Ended | |||
| No | 30-06-2021 | 31-03-2021 | 30-06-2020 | 31-03-2021 | ||
| (Unaudited) | (Audited) | (Unaudited) | (Audited) | |||
| $\mathbf{1}$ | Income | |||||
| (a) Revenue from Operations | 773.48 | 1.393.84 | ||||
| (b) Other income | 18.19 | 7.54 | 1.30 | 13.38 | ||
| Total Income from operations | 18.19 | 781.02 | 1.30 | 1,407.22 | ||
| $\overline{2}$ | Expenses: | |||||
| (a) Cost of materials consumed | 0.33 | 418.48 | 644.87 | |||
| (b) Purchase of stock-in-trade | 602.73 | 602.73 | ||||
| (c) Changes in inventory of finished goods, work-in-progress and stock-in-trade | 125.29 | (424.31) | 13.41 | |||
| (d) Employee benefits expenses | 11.50 | 16.39 | 16.89 | 66.91 | ||
| (e) Finance costs | 0.38 | 1.37 | 2.09 | 10.90 | ||
| (f) Depreciation and amortisation expense | 2.95 | 3.54 | 3.42 | 13.88 | ||
| (g) Other expenses | 18.56 | 37.41 | 20.04 | 112.64 | ||
| Total Expenses | 33.39 | 787.06 | 36.61 | 1,465.33 | ||
| 3 | Profit / (Loss) from ordinary activities before exceptional items (1-2) | (15.21) | (6.04) | (35.31) | (58.11) | |
| $\overline{4}$ | Exceptional items | |||||
| 5 | Profit / (Loss) before tax $(3 + (-4))$ | (15.21) | (6.04) | (35.31) | (58.11) | |
| 6 | Tax expense | |||||
| - Current tax | (0.22) | (0.77) | 0.02 | (0.75) | ||
| - Deferred tax | (4.06) | 0.32 | (8.83) | (12.66) | ||
| Total Tax expenses | (4.28) | (0.45) | (8.81) | (13.41) | ||
| 7 | Profit / (Loss) for the period $(5 + (-6))$ | (10.93) | (5.59) | (26.50) | (44.70) | |
| 8 | Other comprehensive income, net of income tax | |||||
| A. (i) Items that will be reclassified to profit or Loss | ٠ | ٠ | ||||
| (ii) Income tax relating to items that will be reclassified to profit or loss | 1.68 | (1.82) | 0.11 | (2.34) | ||
| B. (i) Items that will not be reclassified to profit or Loss | (0.42) | 0.46 | (0.03) | 0.59 | ||
| (ii) Income tax relating to items that will not be reclassified to profit or loss Total Other comprehensive income, net of income tax |
1.26 | (1.36) | 0.09 | (1.75) | ||
| 9 | Total Comprehensive income for the period $(8 +/-7)$ | (9.67) | (6.95) | (26.42) | (46.45) | |
| 10 | Paid-up equity share capital (Face value of Rs10/- per share) | 24.50 | 24.50 | 24.50 | 24.50 | |
| 11 | Reserve excluding Revalution Reserves as per balance sheet of previous | 1.146.69 | ||||
| accounting year | ||||||
| 12 | Earning per share (EPS) (of Rs.10/- each) (not annualised) | |||||
| Basic / Diluted EPS | (4.46) | (2.28) | (10.82) | (18.25) |
$Proo$ bя
$\overline{a}$
MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS
Registered Office: 4th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001.
Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 (657 E-mall: [email protected] Website: www.triochemproducts.com Corporate Identity Number L24249MH1972PLC015544
| TRIOCHEM PRODUCTS LIMITED | |||
|---|---|---|---|
| Notes: | |||
| 1) | The above unaudited financial results of the Company for the quarter ended June 30, 2021 have been reviewed by the Audit committee of the Board and approved by the Board of Directors at its meeting held on 14.08.2021. |
||
| 2) | The Unaudited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS), the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI). |
||
| 3) | The company has adopted Ind AS 116 effective period beginning from April 01. 2019. The effect of adoption of Ind AS 116 on the financial results is insignificant |
||
| 4) | The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (IND AS-108) "Segment Reporting" is not applicable. |
||
| $\vert 5 \rangle$ | The figure for quarter ended 31st March, 2021 are the balancing figures between audited figures of the full financial year 31st March, 2021 and the reviewed year-to-date figures up to the third quarter of the relevant financial year. |
||
| $\vert 6\rangle$ | The Company has considered the possible effects that may arise out of the still unfolding COVID-19 pandemic on the carrying amounts of property, plant & equipment, inventories, trade receivables, etc. For this purpose, the Company has considered internal and external sources of information up to the date of approval of the Financial Results including credit reports and related information, economic forecasts, market value of certain investments etc. Based on the current estimates, the Company does not expect any significant impact on such carrying values. The impact of COVID-19 on the Company's financial statements may differ from that estimated as at the date of approval of Financial Results. |
||
| 7) | The Indian Parliament has approved the Code on Social Security, 2020 which would impact the contributions by the company towards Provident Fund and Gratuity. The Ministry of Labour and Employment has released draft rules for the Code on Social Security, 2020 on November 13, 2020, and has invited suggestions from stakeholders which are under active consideration by the Ministry. The Company will assess the impact and its evaluation once the subject rules are notified and will give appropriate impact in its financial statements in the period in which, the Code becomes effective and the related rules to determine the financial impact are published. |
||
| 8) | The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary. | ||
| FOR TRIOCHEM PRODUCTS LIMITED $Pro_{\sigma'}$ en rloch, Mullimler RAMU S. DEORA DIRECTOR & CEO Place: Mumbai |
|||
| DIN: 00312369 Dated: 14th August, 2021 |
|||
4
MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS
PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 4657
E-mall: [email protected] Website: www.triochemproducts.com Corporate Identity Number L24249MH1972PLC015544
TRIOCHEM PRODUCTS LIMITED
Registered Office: Sambava Chambers, 4th Floor, Sir P. M. Road, Fort, Mumbai - 400 001
website: www.triochemproducts.com
CIN: L24249MH1972PLC015544
(Rs. in lakhs) Except EPS
CHEM
| EXTRACT OF STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2021 | |||||
|---|---|---|---|---|---|
| Sr | Particulars | For the | For the | For the | For the Year |
| No | Quarter | Quarter | Quarter | Ended on | |
| Ended on | Ended on | Ended on | |||
| $30$ -Jun-21 | 31-Mar-21 | $30 - \frac{1}{20}$ | 31-Mar-21 | ||
| Audited | Unaudited | Unaudited | Audited | ||
| Total Income from operations | 18.19 | 781.02 | 1.30 | 1.407.22 | |
| $\overline{2}$ | Net Profit / (Loss) for the period (before Tax. Exceptional and / or Extraordinary items) | (15.21) | (6.04) | (35.31) | (58.11) |
| $\overline{3}$ | Net Profit / (Loss) for the period before tax (after Exceptional and / or Extraordinary items) | (15.21) | (6.04) | (35.31) | (58.11) |
| $\overline{4}$ | Net Profit / (Loss) for the period after tax (after Exceptional and / or Extraordinary items) | (10.93) | (5.59) | (26.50) | (44.70) |
| $\overline{5}$ | Total Comprehensive Income for the period [Comprising Profit / (Loss) for the period (after | 1.26 | (1.36) | 0.09 | (1.75) |
| tax) and other Comprehensive Income (after tax)] | |||||
| $\overline{6}$ | Equity share capital (Face value Rs. 10/- per share) | 24.50 | 24.50 | 24.50 | 24.50 |
| 7 | Other Equity | 1.146.69 | |||
| 8 | Earnings per share (of Rs.10/- each) (for continuing and discontinued operations) | ||||
| a) Basic (not annualized) | (4.46) | (2.28) | (10.82) | (18.25) | |
| b) Diluted (not annualized) | (4.46) | (2.28) | (10.82) | (18.25) | |
| Notes: | |||||
| 1) The above unaudited financial results of the Company for the quarter ended June 30, 2021 have been reviewed by the Audit committee of the Board |
and approved by the Board of Directors at its meeting held on 14.08.2021.
2) The Unaudited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS), the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).
3) The company has adopted Ind AS 116 effective period beginning from April 01, 2019. The effect of adoption of Ind AS 116 on the financial results is insignificant.
4) The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (IND AS-108) "Segment Reporting" is not applicable.
5) The figure for quarter ended 31st March, 2021 are the balancing figures between audited figures of the full financial year 31st March, 2021 and the reviewed year-to-date figures up to the third quarter of the relevant financial year.
6) The Company has considered the possible effects that may arise out of the still unfolding COVID-19 pandemic on the carrying amounts of property. plant & equipment, inventories, trade receivables, etc. For this purpose, the Company has considered internal and external sources of information up to the date of approval of the Financial Results including credit reports and related information, economic forecasts, market value of certain investments etc. Based on the current estimates, the Company does not expect any significant impact on such carrying values. The impact of COVID-19 on the Company's financial statements may differ from that estimated as at the date of approval of Financial Results.
7) The Indian Parliament has approved the Code on Social Security. 2020 which would impact the contributions by the company towards Provident Fund and Gratuity. The Ministry of Labour and Employment has released draft rules for the Code on Social Security, 2020 on November 13, 2020, and has invited suggestions from stakeholders which are under active consideration by the Ministry. The Company will assess the impact and its evaluation once the subject rules are notified and will give appropriate impact in its financial statements in the period in which, the Code becomes effective and the related rules to determine the financial impact are published.
8) The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary. 9) The above is an extract of the detailed format of financial results filed with the Stock Exchange under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements) Regulation, 2015. The full format of consolidated financial results are available on the Stock Exchange website, www.bseindia.com and on the Company's website www.triochemproducts.com
| FOR TRIOCHEM PRODUCTS LIMITED | ||
|---|---|---|
| ◡ | ||
| ∽ | RAMU S. DEORA | |
| Place: Mumbai | DIRECTOR & CEO | |
| Dated: 14th August, 2021 | DIN: 00312369 |
